Skip to contentM
Microbot Medical Inc.
M
MBOTMicrobot Medical Inc. Q4 2012 · 10-K
Revenue$211.00K$211.00K−61.0% vs Q4 2011 Net Income-$2.76M-$2.76MN/M vs Q4 2011 EPS Diluted-$0.07-$0.07no prior Q4 2011 on file Gross Profitderived$156,029−68.4% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Microbot Medical Inc. · CIK 883975 · Engraved from SEC EDGAR
Operating Incomederived-$6,155,693N/M Operating Cash Flowderived-$4,919,534N/M Free Cash Flowderived-$4,972,888N/M Margins · derivedGross margin73.9%−17.3 pt vs Q4 2011
Operating margin-2917.4%−1566.9 pt vs Q4 2011
Net margin-1307.1%+24.7 pt vs Q4 2011
ended Dec 31, 2012 · filed Mar 21, 2013 · 80 d after period end